Drug control of Ara-C-resistant tumor cells

Minors' rights to refuse medical treatment requested by their parents: remaining issues.

Journal of the American Academy of Nurse Practitioners·2002

Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.

Cancer chemotherapy and pharmacology·1992

Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.

Cancer chemotherapy and pharmacology·1992

Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.

Cancer chemotherapy and pharmacology·1992

Tumor models in drug development.

Cancer metastasis reviews·1991

Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma.

Cancer research·1991

Malawi pilot study of Burkitt lymphoma treatment.

Medical and pediatric oncology·2003

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Medical and pediatric oncology·2003

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Medical and pediatric oncology·2003

Pharmacological management of obesity: Current landscape and emerging therapies.

Indian journal of pharmacology·2026

Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis.

Investigative and clinical urology·2026

Synergistic effects of sorafenib and cilostazol in HepG2 cells.

Journal of biosciences·2026

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

Blood·2026

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer.

Molecular oncology·2026

Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2.

Molecular oncology·2026

Related Experiment Videos

Drug control of Ara-C-resistant tumor cells

Related Concept Videos

Minors' rights to refuse medical treatment requested by their parents: remaining issues.

Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.

Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.

Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.

Tumor models in drug development.

Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma.

Malawi pilot study of Burkitt lymphoma treatment.

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Pharmacological management of obesity: Current landscape and emerging therapies.

Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis.

Synergistic effects of sorafenib and cilostazol in HepG2 cells.

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer.

Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2.

Related Experiment Videos

Drug control of Ara-C-resistant tumor cells

Related Concept Videos

Related Articles